Effects of teriflunomide treatment on cognitive performance and brain volume in patients with relapsing multiple sclerosis: Post hoc analysis of the TEMSO core and extension studies

BACKGROUND: In post hoc analyses of Teriflunomide Multiple Sclerosis Oral study (TEMSO; NCT00134563), teriflunomide 14 mg significantly reduced brain volume loss (BVL) versus placebo in patients with relapsing multiple sclerosis (MS). OBJECTIVE: In this post hoc analysis of TEMSO and its long-term e...

Descripción completa

Detalles Bibliográficos
Autores principales: Sprenger, Till, Kappos, Ludwig, Sormani, Maria Pia, Miller, Aaron E, Poole, Elizabeth M, Cavalier, Steven, Wuerfel, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442776/
https://www.ncbi.nlm.nih.gov/pubmed/35485424
http://dx.doi.org/10.1177/13524585221089534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442776/
https://www.ncbi.nlm.nih.gov/pubmed/35485424
http://dx.doi.org/10.1177/13524585221089534

Ejemplares similares